Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Benign prostatic hyperplasia: from A - Z.

Mostafa M Elhilali1, J Curtis Nickel

  • 1Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada.

The Canadian Journal of Urology
|May 30, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The five amigos: Training and practicing under the living titans of Queen's Urology.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2026
Same author

Variations in Urinary Microbiota on a Short-Duration Space Mission to the International Space Station.

JU open plus·2026
Same author

The sublingual vaccine MV140 is dominant over prophylactic antibiotics for the prevention of recurrent, uncomplicated urinary tract infections in adult women A cost-utility analysis.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2026
Same author

Imaging Mass Cytometry Immune Profiling of Hunner Lesions in a Convenience Sample of Patients With Interstitial Cystitis/Bladder Pain Syndrome.

The Journal of urology·2025
Same author

Patient Related Outcomes for Interstitial Cystitis/Bladder Pain Syndrome Recommendations for Clinical Trials and General Urology Practice.

Neurourology and urodynamics·2025
Same author

Efficacy and safety of drug combinations for chronic pelvic pain: a systematic review.

Pain reports·2025

Medical and surgical treatments for benign prostatic hyperplasia (BPH)-related lower urinary tract symptoms (LUTS) have advanced significantly. Combination therapy with alpha blockers and 5-alpha reductase inhibitors now shows long-term benefits in reducing BPH progression.

Area of Science:

  • Urology
  • Pharmacology
  • Surgical Innovation

Background:

  • Lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) management has evolved.
  • Historically, options were limited to surgery or watchful waiting.

Purpose of the Study:

  • To review the evolution of medical and surgical treatments for BPH-induced LUTS over the past decade.
  • To highlight advancements in pharmacological and minimally invasive surgical approaches.

Main Methods:

  • Review of medical literature and clinical practice changes regarding BPH management.
  • Analysis of the development and application of alpha blockers, 5-alpha reductase inhibitors, and surgical techniques.

Main Results:

  • Alpha blockers have progressed to more selective agents with improved safety profiles.

Related Experiment Videos

  • 5-alpha reductase inhibitors, initially less favored, demonstrate long-term benefits in combination therapy for reducing BPH progression and endpoints like acute urinary retention and surgery.
  • Minimally invasive surgical options and new energy sources (e.g., Holmium laser, bipolar loops) have been introduced for managing BPH, including larger prostates.

    • Conclusions:

    • The last decade has seen significant advancements in both medical and surgical management of BPH.
    • Combination therapy and minimally invasive surgical techniques offer improved outcomes and safety profiles for patients with LUTS secondary to BPH.